In summary, with further research on the immunosuppressive receptors on T cells, an increasing number of results have confirmed that the immunosuppressive receptor TIGIT expressed on the T cell membrane can bind to its ligand on the tumor-specific target cells, inhibit the immune function and promote the escape of tumor cells. This evidence concerns the gene TIGIT and neoplasm.